Add to ORKGAdjuvant use of intravenous immunoglobulin in the treatment of neonatal sepsis: a systematic review with a meta-analysis. J Pediatr (Rio J). 2012;88:377-83. 2. Ohlsson A, Lacy J. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2010;(3):CD001239
Aim: To investigate the effectiveness of IgM-enriched immunoglobulins (IgM-eIVIG) in reducing short-...
Background Sepsis is a major health problem and a leading cause of death among children. Intravenous...
<em>Medications with intravenous immunoglobulin G (IVIG) had established a reputation of effective d...
Neonatal sepsis remains the major cause of mortality and morbidity including neurodevelopmental impa...
BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment...
BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment...
PubMedID: 10832472A total of 76 premature newborn infants with gestational age of 34 weeks or less w...
Infection is a leading cause of mortality and morbidity in the newborn and preterm neonates due to i...
Objective: To evaluate whether intravenous immunoglobulin reduces mortality and length of hospital s...
Despite critical care advances, robust antibiotic therapy and improved strategies in early detection...
Abstract Background Sepsis is an important cause of neonatal death and perinatal brain damage, parti...
<p><em>The report provides the assessment of preterm neonates with perinatal infections (intrauterin...
The medical indications for intravenous immunoglobulin (IVIG) use in neonates include hemolytic dise...
Introduction: Newborn children conceived before 32 weeks of incubation are genuinely immune deficien...
Introduction: Neonatal sepsis is still one of the major causes of morbidity and mortality in neonate...
Aim: To investigate the effectiveness of IgM-enriched immunoglobulins (IgM-eIVIG) in reducing short-...
Background Sepsis is a major health problem and a leading cause of death among children. Intravenous...
<em>Medications with intravenous immunoglobulin G (IVIG) had established a reputation of effective d...
Neonatal sepsis remains the major cause of mortality and morbidity including neurodevelopmental impa...
BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment...
BACKGROUND: Neonatal sepsis is a major cause of death and complications despite antibiotic treatment...
PubMedID: 10832472A total of 76 premature newborn infants with gestational age of 34 weeks or less w...
Infection is a leading cause of mortality and morbidity in the newborn and preterm neonates due to i...
Objective: To evaluate whether intravenous immunoglobulin reduces mortality and length of hospital s...
Despite critical care advances, robust antibiotic therapy and improved strategies in early detection...
Abstract Background Sepsis is an important cause of neonatal death and perinatal brain damage, parti...
<p><em>The report provides the assessment of preterm neonates with perinatal infections (intrauterin...
The medical indications for intravenous immunoglobulin (IVIG) use in neonates include hemolytic dise...
Introduction: Newborn children conceived before 32 weeks of incubation are genuinely immune deficien...
Introduction: Neonatal sepsis is still one of the major causes of morbidity and mortality in neonate...
Aim: To investigate the effectiveness of IgM-enriched immunoglobulins (IgM-eIVIG) in reducing short-...
Background Sepsis is a major health problem and a leading cause of death among children. Intravenous...
<em>Medications with intravenous immunoglobulin G (IVIG) had established a reputation of effective d...